Attempted reduction of Abbott MS-2 false-susceptible errors for cefotaxime-resistant Pseudomonas aeruginosa by medium modification.

AUTOR(ES)

Lander, D W

RESUMO

Thirty-five modifications of Abbott MS-2 growth medium were evaluated in an attempt to reduce the high frequency of false-susceptible errors produced by the MS-2 system when testing resistant Pseudomonas aeruginosa against cefotaxime. A hypotonic modification with 0.1% KNO3 reduced the errors from 41 to 20% for 23 resistant isolates. All hypertonic modifications proved unsatisfactory. No modification reduced false-susceptible errors to acceptable clinical levels.

Documentos Relacionados

• False-Susceptible Results from the MS-2 System Used for Testing Resistant Pseudomonas aeruginosa Against Two Third-Generation Cephalosporins, Moxalactam and Cefotaxime
• False-susceptible results from the MS-2 system used for testing resistant Pseudomonas aeruginosa against two third-generation cephalosporins, moxalactam and cefotaxime.
• Cefotaxime-resistant Nocardia asteroides strains are isolates of the controversial species Nocardia farcinica.
• Methicillin-resistant Staphylococcus aureus susceptibility testing with Abbott MS-2 system.
• Infected abdominal aortic aneurysm due to penicillin-, ceftriaxone-, and cefotaxime-resistant Streptococcus pneumoniae.